These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15999051

  • 41. Gemzar platinum combinations: phase III trials in non-small cell lung cancer.
    Crinò L, Calandri C.
    Lung Cancer; 2002 Nov; 38 Suppl 2():S9-12. PubMed ID: 12431823
    [Abstract] [Full Text] [Related]

  • 42. [A case of primary malignant hemangiopericytoma of the lung with marked response to combination chemotherapy with cisplatin, ifosfamide and gemcitabine].
    Fujita A, Minase T, Takabatake H, Tagaki S, Sekine K.
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):373-6. PubMed ID: 11265407
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer.
    Davidov MI, Polotzky BE, Marenich AF, Orlov SV, Lazarev AF, Skryabina LS, Pavlushkov EV, Semenchenya VA, Brichkova OY, Karaseva VV.
    Anticancer Drugs; 2011 Jul; 22(6):569-75. PubMed ID: 21487288
    [Abstract] [Full Text] [Related]

  • 45. A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.
    Kontopodis E, Kotsakis A, Kentepozidis N, Syrigos K, Ziras N, Moutsos M, Filippa G, Mala A, Vamvakas L, Mavroudis D, Georgoulias V, Agelaki S.
    Cancer Chemother Pharmacol; 2016 May; 77(5):949-56. PubMed ID: 26994909
    [Abstract] [Full Text] [Related]

  • 46. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA, Cormier Y, Burkes R, Evans WK, Goss G, Klimo P, Feld R, Taylor M.
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [Abstract] [Full Text] [Related]

  • 47. Gemcitabine shows promise as combination agent in NSCLC.
    Oncology (Williston Park); 1996 Sep; 10(9):1311. PubMed ID: 9052981
    [No Abstract] [Full Text] [Related]

  • 48. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
    Colucci G, Giuliani F, Gebbia V, Biglietto M, Rabitti P, Uomo G, Cigolari S, Testa A, Maiello E, Lopez M.
    Cancer; 2002 Feb 15; 94(4):902-10. PubMed ID: 11920457
    [Abstract] [Full Text] [Related]

  • 49. Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.
    Malik IA, Aziz Z, Zaidi SH, Sethuraman G.
    Am J Clin Oncol; 2003 Apr 15; 26(2):174-7. PubMed ID: 12714891
    [Abstract] [Full Text] [Related]

  • 50. Gemcitabine and platinum combinations in pancreatic cancer.
    Philip PA.
    Cancer; 2002 Aug 15; 95(4 Suppl):908-11. PubMed ID: 12209670
    [Abstract] [Full Text] [Related]

  • 51. Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.
    Ueno H, Okusaka T, Ikeda M, Morizane C, Ogura T, Hagihara A, Tanaka T.
    Jpn J Clin Oncol; 2007 Jul 15; 37(7):515-20. PubMed ID: 17675286
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.
    Zhang X, Lu J, Xu J, Li H, Wang J, Qin Y, Ma P, Wei L, He J.
    Respirology; 2013 Jan 15; 18(1):131-9. PubMed ID: 22882698
    [Abstract] [Full Text] [Related]

  • 54. Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer.
    Hasturk S, Hatabay N, Ece F, Karatasli M, Hanta I.
    Am J Clin Oncol; 2009 Jun 15; 32(3):280-5. PubMed ID: 19433960
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V, Galetta D, Caruso M, Verderame F, Pezzella G, Valdesi M, Borsellino N, Pandolfo G, Durini E, Rinaldi M, Loizzi M, Gebbia N, Valenza R, Tirrito ML, Varvara F, Colucci G, Gruppo Ocologico Italia Meridionale.
    Lung Cancer; 2003 Feb 15; 39(2):179-89. PubMed ID: 12581571
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P, Massacesi C, Rocchi MB, Mattioli R, Lippe P, Trivisonne R, Buzzi F, De Signoribus G, Tuveri G, Rossi G, Di Lullo L, Sturba F, Morale D, Catanzani S, Pilone A, Bonsignori M, Battelli T.
    Lung Cancer; 2003 Jul 15; 41(1):81-9. PubMed ID: 12826316
    [Abstract] [Full Text] [Related]

  • 60. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.
    Giaccone G, Herbst RS, Manegold C, Scagliotti G, Rosell R, Miller V, Natale RB, Schiller JH, Von Pawel J, Pluzanska A, Gatzemeier U, Grous J, Ochs JS, Averbuch SD, Wolf MK, Rennie P, Fandi A, Johnson DH.
    J Clin Oncol; 2004 Mar 01; 22(5):777-84. PubMed ID: 14990632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.